Srini Conjeevaram

Srini Conjeevaram is a declared insider at 2 companies; the most frequent names are Derma Sciences, Inc. and Encore Medical Corp. Over a trading history stretching from 20 October 2004 to 24 February 2017, the count stands at 28 filings.

In open-market terms, that means 1 purchase worth €6,482 on one side and 3 sales worth €173k on the other. Sales outweigh purchases by €166k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 11 share grants and 7 option exercises.

The newest entry dates from 24 February 2017: a transaction, in Derma Sciences, Inc. The most recent open-market purchase was published on 18 August 2015, 4,084 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.